Showing 1 - 10 of 25
Persistent link: https://www.econbiz.de/10001177296
Persistent link: https://www.econbiz.de/10002377387
Persistent link: https://www.econbiz.de/10010848992
Based on our decision analysis, the additional costs for achieving incremental effectiveness with single-inhaler salmeterol/fluticasone propionate treatment compared with FPIC and nFPIC may be lower than the commonly accepted benchmark value for cost effectiveness, based on published estimates...
Persistent link: https://www.econbiz.de/10011001525
Several types of cost-effectiveness studies remain under-represented in the literature on targeted OAMs, including those for follow-on indications approved after the initial indication for a drug and for off-label indications, head-to-head comparisons of targeted OAMs with other targeted OAMs...
Persistent link: https://www.econbiz.de/10011001676
<Emphasis Type="Bold">Introduction: Since their invention in the late 1980s and early 1990s, selective serotonin reuptake inhibitors (SSRIs) have become the primary form of pharmaceutical treatment for depression. As the patents of several top-selling SSRIs have expired or are soon to be expired, the SSRI market is...</emphasis>
Persistent link: https://www.econbiz.de/10011001680
Thoroughness of care was the strongest determinant of patient satisfaction, followed by physician listening and explanation. Especially with patients’ improved access to current medical information, it is important for physicians to recognize that excellent communication cannot serve as a...
Persistent link: https://www.econbiz.de/10011240993
Persistent link: https://www.econbiz.de/10000741624
Persistent link: https://www.econbiz.de/10003502037
Persistent link: https://www.econbiz.de/10010531288